Cirrhosis-associated immune dysfunction

A Albillos, R Martin-Mateos, S Van der Merwe… - Nature Reviews …, 2022 - nature.com
The term cirrhosis-associated immune dysfunction (CAID) comprises the distinctive
spectrum of immune alterations associated with the course of end-stage liver disease …

The gut-liver axis in liver disease: Pathophysiological basis for therapy

A Albillos, A De Gottardi, M Rescigno - Journal of hepatology, 2020 - Elsevier
The gut-liver axis refers to the bidirectional relationship between the gut and its microbiota,
and the liver, resulting from the integration of signals generated by dietary, genetic and …

[HTML][HTML] The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

V Arroyo, P Angeli, R Moreau, R Jalan, J Clària… - Journal of …, 2021 - Elsevier
Acute decompensation (AD) of cirrhosis is defined by the development of ascites, hepatic
encephalopathy (HE) and/or variceal bleeding. Ascites is traditionally attributed to …

[HTML][HTML] Gut–liver axis: how do gut bacteria influence the liver?

PC Konturek, IA Harsch, K Konturek, M Schink… - Medical …, 2018 - mdpi.com
Chronic liver diseases are a major cause of morbidity and mortality worldwide. Recently, gut
dysbiosis was identified as an important factor in the pathogenesis of liver diseases. The …

The gut–liver axis: Host microbiota interactions shape hepatocarcinogenesis

MAD Silveira, S Bilodeau, TF Greten, XW Wang… - Trends in cancer, 2022 - cell.com
Although their etiologies vary, tumors share a common trait: the control of an oncogenic
transcriptional program that is regulated by the interaction of the malignant cells with the …

Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis

SR Gurusamy, A Shah, NJ Talley… - Official journal of the …, 2021 - journals.lww.com
METHODS: Electronic databases were searched until July 2020 for studies reporting
prevalence of SIBO in FD. The prevalence rates, odds ratio, and 95% confidence intervals …

The spectrum of small intestinal bacterial overgrowth (SIBO)

EMM Quigley - Current gastroenterology reports, 2019 - Springer
Abstract Purpose of Review To critically review recent (past 3 years) literature on the
definition, diagnosis, and management of small intestinal bacterial overgrowth (SIBO) …

A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals

M Ahadi, K Molooghi, N Masoudifar… - Journal of …, 2021 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) is one of the most common causes of hepatic
disorders. It represents a wide range of chronic liver diseases in patients with no history of …

[HTML][HTML] Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility …

UC Ghoshal, S Sachdeva, U Ghoshal, A Misra… - Indian Journal of …, 2022 - Springer
In the clinical setting, small intestinal bacterial overgrowth (SIBO) is a frequent, but under-
diagnosed entity. SIBO is linked to various gastrointestinal (GI) and non-GI disorders with …

[HTML][HTML] The prevalence of small intestinal bacterial overgrowth in patients with non-alcoholic liver diseases: NAFLD, NASH, fibrosis, cirrhosis—a systematic review …

A Gudan, D Jamioł-Milc, V Hawryłkowicz… - Nutrients, 2022 - mdpi.com
Bacterial overgrowth in the small intestine (SIBO) is a pathological growth of the intestinal
microbiota in the small intestine that causes clinical symptoms and can lead to digestive and …